This inventor holds 7 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents. Top assignees: Biogenerix Ag, Ratiopharm Gmbh, Biogenerix Gmbh. Active years: 2000-2016.
Company Filing History:
3 out of 9 
2 out of 52 
1 out of 3 Years Active: 2000-2016
Title: Walter Hinderer: Innovator in Pharmaceutical Formulations
Introduction
Walter Hinderer is a notable inventor based in Rodgau, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid formulations of G-CSF. With a total of 7 patents to his name, Hinderer's work has had a substantial impact on medical treatments.
Latest Patents
Hinderer's latest patents include innovative methods for preparing a liquid formulation of G-CSF. These formulations are designed to be stable over extended periods and are substantially free of excipients. Additionally, he has developed ready-to-use syringes containing these formulations, along with corresponding kits. Another significant patent focuses on the method of treatment using these stable liquid formulations of G-CSF, further enhancing their practical application in medical settings.
Career Highlights
Throughout his career, Walter Hinderer has worked with prominent companies in the pharmaceutical industry, including Biogenerix AG and Ratiopharm GmbH. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking advancements in drug formulation.
Collaborations
Hinderer has collaborated with several professionals in his field, including Christian Scheckermann and Heinz Lubenau. These partnerships have facilitated the exchange of ideas and fostered innovation in pharmaceutical development.
Conclusion
Walter Hinderer stands out as a key figure in the pharmaceutical industry, with his inventions paving the way for improved medical treatments. His dedication to developing stable formulations of G-CSF demonstrates his commitment to enhancing patient care.